about
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objec...
Read More
8.26
-0.25
(-2.94%)
660.3K
XNAS Volume
XNAS 15 Jul, 2025 12:37 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Immunome Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..